Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Zydus Lifesciences Limited | Ahmedabad, India | Makes it and tests it | Problems found, fixed voluntarilyJun 17, 2025 · 9 inspections, 1 with FDA action |
Recalls
- Jul 29, 2026 · Class II · Shilpa Medicare Limited
Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials
Lots: Lot: P400172; Lot PA00050A, Exp 09/30/2027 - Jul 29, 2026 · Class II · Shilpa Medicare Limited
Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials
Lots: Lot: P400157, Exp 08/31/2026; Lot PA00047A, Exp 09/30/2027
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Pemetrexed: every company that makes it
- Form
- injection, intravenous
- Strength
- 500 mg per 50 mL
- Approval
- NDA NDA215179
- On the market since
- Jun 6, 2023
- Package NDCs
70121-2461-1- Official label
- DailyMed (National Library of Medicine), updated Jul 8, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?